The North American Immune Tolerance Registry: Practices, outcomes, outcome predictors

Thrombosis and Haemostasis

Volumn 87, Issue 1, 2002, Pages 52-57

  DiMichele, Donna M ^a   Kroner, B L ^a   Adair, S ^a   Addiego, J ^a   Anderson, V ^a   Barbosa, J ^a   Blatt, P ^a   Bockenstedt, P ^a   Castle, V ^a   Chenaille, P ^a   Cohen, J ^a   Czapek, E ^a   Davis, J ^a   Davignon, G ^a   De Alarcon, P ^a   Dubowy, R ^a   DuCore, J ^a   Dugdale, M ^a   Ewenstein, B ^a   Fahner, J ^a   Gribble, T John ^a   Gnarra, D ^a   Gruppo, R ^a   Hakami, N ^a   Hanna, M ^a   Hanna, W ^a   Haut, P ^a   Heggie, G ^a   Homans, A ^a   Hutter, J ^a   Johnson, C ^a   Kajani, M ^a   Karpatkin, M ^a   Kasper, Casper ^a   Katz, J ^a   Kessler, C ^a   Key, N ^a   Koerper, M ^a   Konkle, B ^a   Kosinski, R ^a   Lazerson, J ^a   Lightsey, A ^a   Loew, T ^a   Lusher, J ^a   MacLaughlin, W ^a   Manco Johnson, M ^a   Manno, C ^a   McRedmond, K ^a   Phatak, P ^a   Powell, J ^a   Ragni, M ^a   Rosenfield, C ^a   Sanders, J ^a   Santiago Borrero, P ^a   Saidi, P ^a   Seeler, R ^a   Seremetis, S ^a   Sexauer, J ^a   Travis, S ^a   Valdez, L ^a   Warner, E ^a   White, G ^a   Barrand, D ^a   Drown, J ^a   Herst, J ^a   Inwood, M ^a   Lillicrap, D ^a   Rivard, G ^a   Rubin, S ^a   Stranczyniski, H ^a   Teitel, J ^a   more..

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Hemophilia A; Hemophilia B; Immune tolerance; Inhibitor therapy

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 9; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ALLERGIC REACTION; ANTIBODY TITER; ARTICLE; BLEEDING; CANADA; CATHETER; CATHETER INFECTION; CHILD; CORRELATION ANALYSIS; GASTROINTESTINAL TOXICITY; HAIR LOSS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HYPERTENSION; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; NEPHROTIC SYNDROME; NORTH AMERICA; OUTCOMES RESEARCH; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTRATION; RESPIRATORY TRACT DISEASE; SHOCK; TREATMENT FAILURE; UNITED STATES;

EID: 0036147943     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612943     Document Type: Article

References (27)

1. Incidence of development of FVIII and FIX inhibitors in haemophiliacs
2. Inhibitors in Christmas disease
3. Treatment of hemophiliacs with inhibitors: Cost and effect on blood resources
4. Massive FVIII infusion in a haemophiliac with FVIII inhibitor, high responder
5. Induced immunotolerance in FVIII inhibitor patients
6. The importance of corticoids added to continued treatment with FVIII concentrates in the suppression of inhibitors in hemophilia A
7. Disappearance of FVIII:C antibodies in patients with haemophilia upon frequent administration of FVIII in intermediate or low dose
8. Induction of immune tolerance to FVIII in hemophiliacs with inhibitors
9. Induction of immune tolerance in patients with hemophilia and antibodies to FVIII by combined treatment with intravenous IgG, cyclophosphamide and FVIII
10. Induction of immune tolerance in patients with hemophilia A and inhibitors
11. Low dose immune tolerance induction in hemophilia A patients with inhibitors
12. Immune tolerance therapy in paediatric hemophiliacs with FVIII inhibitors: 14 years follow up
13. Immune tolerance for the treatment of FVIII inhibitors - Twenty years' 'Bonn Protocol'
14. Immunoadsorption for removal of inhibitors: Update on treatments in Malmo-Lund between 1980 and 1995
15. Tolerance induction using the Malmo treatment model 1982-1995
16. Induction of immune tolerance in HA inhibitor patients by the 'Bonn Protocol': Predictive parameter for therapy duration and outcome
17. Induction of split tolerance and clinical cure in high-responding hemophiliacs with FIX antibodies
18. Immune tolerance in hemophilia. Principal results from the international registry
19. International immune tolerance registry, 1997 update
20. Comparison of the international immune tolerance registry and the North American immune tolerance registry
21. The natural history of FVIII inhibitors in patients with hemophilia A
22. Increased frequency of inhibitors in African American hemophilia A patients
23. FIX inhibitors and anaphylaxis in hemophilia B
24. FIX antibody and immune tolerance
25. Nephrotic syndrome as a complication of immune tolerance in hemophilia B (letter)